Biogen Inc. buy Royal Bank of Canada
Start price
04.10.24
/
50%
€168.70
Target price
04.10.25
€245.41
Performance (%)
0.27%
Price
04.10.24
€169.15
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Biogen Inc. is nearly unchanged. This prediction currently runs until 04.10.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Biogen Inc. | 0.27% |
iShares Core DAX® | -1.114% |
iShares Nasdaq 100 | 1.816% |
iShares Nikkei 225® | 2.113% |
iShares S&P 500 | 2.038% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Royal Bank of Canada from $292.00 to $269.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat